Search API
US CDC nasal sampling program provides information about a virus variant transmissibility
March 14, 2024
TP-05 demonstrated tolerability and statistically significant tick mortality
February 25, 2024
Vector-Borne Diseases Expand Health Risks in 2024
February 9, 2024
OspA mRNA-LNP vaccine targets Lyme disease causing bacteria
September 20, 2023
VLA15 is a multivalent recombinant protein Lyme disease vaccine candidate
June 10, 2023
Novel oral Lyme disease vaccine reduces wildlife spread of Borrelia burgdorferi
May 10, 2023
SARS-CoV-2 XBB.1.5 accounts for 52% of sequenced lineages
January 25, 2023
VLA15 vaccine antibody levels remained above baseline at six months
December 1, 2022
Lyme disease vaccine candidate continues phase 3 clinical trial
October 10, 2022
- 1 of 15
- next ›